WHO ICTRP trial
A double-blind, randomised, placebo controlled, single dose, two-period…
EUCTR2006-002632-21-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002632-21-GB |
|---|---|
| Public title | A double-blind, randomised, placebo controlled, single dose, two-period crossover study to investigate the therapeutic potential of the TRPV1 antagonist SB-705498 in treatment of subjects with rectal hypersensitivity including irritable bowel syndrome. |
| Scientific title | A double-blind, randomised, placebo controlled, single dose, two-period crossover study to investigate the therapeutic potential of the TRPV1 antagonist SB-705498 in treatment of subjects with rectal hypersensitivity including irritable bowel syndrome. |
| Primary sponsor | GlaxoSmithKline Research & Development |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Rectal Hyperalgesia (in patients with irritable bowel syndrome and feacal urgency) MedDRA version: 8.1 Level: LLT Classification code 10038072 Term: Rectal pain |
| Interventions | Product Name: SB-705498 Pharmaceutical Form: Film-coated tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Pharmaceutical form of the placebo: Film-coated tablet Route of administration of the… |
| Registration date | Sep 10, 2006 |
| Target size | 42 |
| Secondary IDs | VRA107438 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: